Eli Lilly CEO: The Weight-Loss Drug Revolution, AI in Pharma, and Innovation

This podcast features an interview with David Ricks, CEO of Eli Lilly, focusing on the company's GLP-1 weight-loss drugs and their unexpected applications. The conversation covers the drug's discovery, its effectiveness in treating various conditions (including potential benefits for alcoholism and Alzheimer's), and the challenges of drug development and pricing. Ricks details Eli Lilly's strategies for accelerating drug discovery, emphasizing parallel processing and efficient decision-making. He also discusses the company's approach to pricing, balancing profitability with ethical considerations and societal impact, citing the eventual affordability of generic drugs as a key benefit. The interview concludes with Ricks sharing his personal approach to leadership and advice for young people.

Outlines

Part 1: GLP-1 Introduction and Impact

Part 2: Drug Discovery and Development Process

Part 3: Leadership, Culture, and Strategy

Part 4: Final Thoughts

Sign in to continue reading, translating and more.

Open full episode in Podwise

In Good Company with Nicolai Tangen

Part 1: GLP-1 Introduction and Impact

Introduction and Eli Lilly's GLP-1 Journey

Broad Effects and Future Potential of GLP-1 Drugs

The Future of Weight Management and the Obesity Epidemic

Part 2: Drug Discovery and Development Process

The Challenges and Costs of Drug Discovery

Eli Lilly's Approach to Drug Discovery and Development

Key Factors in Accelerating Drug Development

The Role of AI in Drug Discovery and Development

Comparing Drug Development and Market Access Across Regions

Part 3: Leadership, Culture, and Strategy

David Ricks' Leadership Style and Fostering a Culture of Learning

Leadership Under Pressure and Learning from External Voices

Ethical Dilemmas in Pricing and Affordability

Pricing Decisions and Real-World Evidence

Eli Lilly's Corporate Culture and Combating Bureaucracy

Leadership Growth and Strategic Focus

Speed as a Leadership Mindset and the CEO/Chair Debate

Part 4: Final Thoughts

Personal Reflections and Advice for Young People

Eli Lilly CEO: The Weight-Loss Drug Revolution, AI in Pharma, and Innovation

In Good Company with Nicolai Tangen

Part 1: GLP-1 Introduction and Impact

00:01Introduction and Eli Lilly's GLP-1 Journey

Introduction and Eli Lilly's GLP-1 Journey

02:15Broad Effects and Future Potential of GLP-1 Drugs

Broad Effects and Future Potential of GLP-1 Drugs

04:12The Future of Weight Management and the Obesity Epidemic

The Future of Weight Management and the Obesity Epidemic

Part 2: Drug Discovery and Development Process

05:43The Challenges and Costs of Drug Discovery

The Challenges and Costs of Drug Discovery

08:10Eli Lilly's Approach to Drug Discovery and Development

Eli Lilly's Approach to Drug Discovery and Development

10:53Key Factors in Accelerating Drug Development

Key Factors in Accelerating Drug Development

13:19The Role of AI in Drug Discovery and Development

The Role of AI in Drug Discovery and Development

17:15Comparing Drug Development and Market Access Across Regions

Comparing Drug Development and Market Access Across Regions

Part 3: Leadership, Culture, and Strategy

22:19David Ricks' Leadership Style and Fostering a Culture of Learning

David Ricks' Leadership Style and Fostering a Culture of Learning

24:55Leadership Under Pressure and Learning from External Voices

Leadership Under Pressure and Learning from External Voices

30:27Ethical Dilemmas in Pricing and Affordability

Ethical Dilemmas in Pricing and Affordability

33:38Pricing Decisions and Real-World Evidence

Pricing Decisions and Real-World Evidence

36:43Eli Lilly's Corporate Culture and Combating Bureaucracy

Eli Lilly's Corporate Culture and Combating Bureaucracy

41:53Leadership Growth and Strategic Focus

Leadership Growth and Strategic Focus

44:48Speed as a Leadership Mindset and the CEO/Chair Debate

Speed as a Leadership Mindset and the CEO/Chair Debate

Part 4: Final Thoughts

50:17Personal Reflections and Advice for Young People

Personal Reflections and Advice for Young People